Drug maker Pfizer is seeking to exclude the testimony of four of the plaintiff experts in the Zoloft Multidistrict Litigation, in which plaintiffs allege the antidepressant caused birth defects in babies.
In one motion, Pfizer said Anick Bérard, a pharmacoepidemiologist, should be excluded because her testimony would be “unreliable, methodologically flawed, and inadmissible.” For example, the drug maker says that Bérard presented only findings that supported her opinion, while not addressing data that runs counter to her opinion.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
